An Act to promote transparency and cost control of pharmaceutical drug prices
By Mr. Montigny, a petition (accompanied by bill, Senate, No. 1048) of Mark C. Montigny, Jason M. Lewis, James B. Eldridge, Michael O. Moore and other members of the General Court for legislation to promote transparency and cost control of pharmaceutical drug prices. Mental Health and Substance Abuse.
Petitioners
| Name | District/Address |
|---|---|
| Mark C. Montigny | Second Bristol and Plymouth |
| Jason M. Lewis | Fifth Middlesex |
| James B. Eldridge | Middlesex and Worcester |
| Michael O. Moore | Second Worcester |
| Denise Provost | 27th Middlesex |
| Stephen L. DiNatale | 3rd Worcester |
| Joseph W. McGonagle, Jr. | 28th Middlesex |
| Lori A. Ehrlich | 8th Essex |
| Jose F. Tosado | 9th Hampden |
| Marjorie C. Decker | 25th Middlesex |
| Ruth B. Balser | 12th Middlesex |
| Michael D. Brady | Second Plymouth and Bristol |
| Paul R. Heroux | 2nd Bristol |
| Patricia D. Jehlen | Second Middlesex |
| Kay Khan | 11th Middlesex |
| Antonio F. D. Cabral | 13th Bristol |
| Jennifer E. Benson | 37th Middlesex |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.